TLIS

Talis Biomedical Corporation [TLIS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

TLIS Stock Summary

In the News

TLIS Financial details

Company Rating
-
Market Cap
15.46M
Income
-60.84M
Revenue
412K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
99
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-1.14
Forward P/E
-
PEG
0.2
P/S
697.36
P/B
0.18
P/C
-
P/FCF
-4.58
Quick Ratio
10.41
Current Ratio
10.6
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-26.63
EPS next Y
-
EPS next Q
-
EPS this Y
-45.36%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
34.65%
Revenue last 5Y
-36.46%
Revenue Q/Q
98.68%
EPS Q/Q
-95.13%
-
-
-
-
SMA20
-16.99%
SMA50
-18.59%
SMA100
-24.85%
Inst Own
-
Inst Trans
-
ROA
-12%
ROE
-12%
ROC
-0.81%
Gross Margin
-543%
Oper. Margin
-21867%
Profit Margin
-3501%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4.35-9.32
52W High
-84.33%
52W Low
-64.75%
RSI
55.21
Rel Volume
0.01
Avg Volume
8.45K
Volume
100
Perf Week
12.8%
Perf Month
0%
Perf Quarter
-13.5%
Perf Half Y
-10.19%
-
-
-
-
Beta
1.738
-
-
Volatility
0.06%, 0.14%
Prev Close
12.8%
Price
1.41
Change
12.8%

Something similar

Top by Market Cap
Same Sector
Same Price Range
Similar Market Cap